Liminal BioSciences Inc. PFSCF

RE:RE:RE:Just a thought

[Biofinder]

Yes wanker GunnerG “inferences” and “extrapolations” from a presentation are difficult concepts to comprehend for low IQ individuals like yourself. Anyone with medical knowledge knows plasminogen is involved in all aspects of the body’s healing process; there have been numerous of research articles written on plasminogen and the healing process. You wankerG should have graduated high school instead of being a dropout then you could have learned to read and comprehend instead of becoming a jerkoff in life.

GunnerG wrote: Creaton, maybe you should pay attention to the facts instead of following pumpers blindly.

Bio, you make up so much of what you post.  The highlighted green was never said in the CC.

"Thanks to independent research conducted on Ryplazim, physicians are salivating ...."

They said physicians are enthusiastic and want to undertake clinical trials.  

Biofinder wrote: creaton: the CC stated that Ryplazim will treat indications in the Thrombosis and Cardiovascular indications, which are large, so it appears Ryplazim will get a nice slice of the pie as I posted below:

The $8 Billion USD Ryplazim market just Doubled in Size!

Today’s CC indicated that Ryplazim will be entering the following markets:

 

• Thrombosis 
• Cardiovascular 

 

Thanks to independent research conducted on Ryplazim, physicians are salivating over the prospect of using Ryplazim to treat an array of ailments in the Thrombosis and Cardiovascular indications.

“Morgan Stanley forecasts the global Thrombosis market size to increase from $5.1 billion in 2002 to $16.2 billion in 2010, with 65% of this revenue growth expected to come from the US market.”

“The cardiovascular disease market, which includes hypertension, dyslipidaemia and thrombotic events, is set to grow from $129.2 billion in 2015 to $146.4 billion by 2022.”

I’ve been saying this for some time now: the Ryplazim market is much larger than the stated $8 Billion USD. 

More indications to be announced...

Read more at https://www.stockhouse.com/companies/bullboard/t.pli/prometic-life-sciences-inc?postid=28237794#kULUVEA66e8UrZ3s.99

creaton wrote: Why bio thinks that plasminogen market has doubled?
well probably and this isn’t factual but my own thinking is because it can be used for  more indications ..so multiple uses is a good thing..

not it sure but I think with them saying the wound healing and the diabetic foot ulcer programs on hold and they don’t put a lot of emphasis on ivig  at the moment maybe had something to do with some selling today.

i thought the RBC guy was doing a lot of mumbling and wanted dates  which they can’t provide atm
do to their hires consultants taking cTe of what they need to to get the job done and fda takes their time as well..maybe he smoking some weed stocks